Cardiol Therapeutics Inc. Share Premium
Cardiol Therapeutics Inc. (CRDL) had Share Premium of CAD 29.08 million as of 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:SharePremium · last filed 2026-03-31
- 2025-12-31: Share Premium 29.08M CAD.
- 2024-12-31: Share Premium 24.65M CAD.
- 2023-12-31: Share Premium 18.79M CAD.
- 2022-12-31: Share Premium 15.59M CAD.
| Period end | Share Premium |
|---|---|
| 2025-12-31 | 29.08M CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | 24.65M CAD 40-F · filed 2026-03-31 |
| 2023-12-31 | 18.79M CAD 40-F · filed 2025-03-31 |
| 2022-12-31 | 15.59M CAD 20-F · filed 2024-04-01 |
| 2021-12-31 | 12.66M CAD 20-F · filed 2023-03-29 |
| 2020-12-31 | 8.77M CAD 40-F/A · filed 2022-04-20 |